Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4103960
Max Phase: Preclinical
Molecular Formula: C30H35N6NaO10
Molecular Weight: 640.65
Molecule Type: Small molecule
Associated Items:
ID: ALA4103960
Max Phase: Preclinical
Molecular Formula: C30H35N6NaO10
Molecular Weight: 640.65
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H]1[C@H]([C@H](O)[C@H](O)CNC(=O)C(N)=O)O[C@@](OCCCn2cc(-c3ccc(-c4ccccc4)cc3)nn2)(C(=O)[O-])C[C@@H]1O.[Na+]
Standard InChI: InChI=1S/C30H36N6O10.Na/c1-17(37)33-24-22(38)14-30(29(43)44,46-26(24)25(40)23(39)15-32-28(42)27(31)41)45-13-5-12-36-16-21(34-35-36)20-10-8-19(9-11-20)18-6-3-2-4-7-18;/h2-4,6-11,16,22-26,38-40H,5,12-15H2,1H3,(H2,31,41)(H,32,42)(H,33,37)(H,43,44);/q;+1/p-1/t22-,23+,24+,25+,26+,30+;/m0./s1
Standard InChI Key: MTXQABHQAZXPMU-RHQQZYLRSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 640.65 | Molecular Weight (Monoisotopic): 640.2493 | AlogP: -1.22 | #Rotatable Bonds: 13 |
Polar Surface Area: 248.45 | Molecular Species: ACID | HBA: 12 | HBD: 7 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 8 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 3.09 | CX Basic pKa: | CX LogP: -0.47 | CX LogD: -3.93 |
Aromatic Rings: 3 | Heavy Atoms: 46 | QED Weighted: 0.09 | Np Likeness Score: -0.14 |
1. Prescher H, Frank M, Gütgemann S, Kuhfeldt E, Schweizer A, Nitschke L, Watzl C, Brossmer R.. (2017) Design, Synthesis, and Biological Evaluation of Small, High-Affinity Siglec-7 Ligands: Toward Novel Inhibitors of Cancer Immune Evasion., 60 (3): [PMID:28103033] [10.1021/acs.jmedchem.6b01111] |
Source(1):